Table 3.
Summary of facility SPARS effectiveness scores (SPARS-ES), MMS supportive supervision (SS) competency scores and MMS experience*
| Medicines management supervisors (MMS) | SPARS –ES** | Supportive supervision competency score (%) median | Total # of SPARS visits implemented in 2012* |
|---|---|---|---|
| MMS of facilities with high SPARS-ES | |||
| MMS a (C) | 4.0 | 56% | 20 |
| MMS b (P) | 4.0 | 0% | 6 |
| MMS c (C) | 3.7 | 71% | 25 |
| MMS d (C) | 2.3 | 40% | 43 |
| MMS e (C) | 1.6 | 77% | 11 |
| Median | 3.7 | 57% | 20 |
| MMS of facilities with low SPARS-ES | |||
| MMS f (P) | 1.4 | 22% | 8 |
| MMS g (P) | 1.4 | 37% | 24 |
| MMS h (C) | 1.1 | 22% | 14 |
| MMS i (P) | 0.5 | 17% | 19 |
| MMS j (C) | 0.3 | 55% | 22 |
| Median | 1.1 | 24% | 19 |
| Median overall | 2.0 | 38% | 19 |
*MMS experience defined as total number of SPARS visits implemented 2012
**average facility improvement in medicines management across visits by the MMS in 2012, on a scale from 0 to 25; C: clinician; P: pharmacy-trained